Arcutis Biotherapeutics, Inc. (ARQT) stock
ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30368% above fair value
$28.26+0.73 (+2.65%)
Close on Nov 13, 2026Market cap $3.55BP/E 128.5Yield –
Arcutis Biotherapeutics statistics
94 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 15.39
- 2.22
- P/OCF Ratio
- 59.24
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 6.69
- 2.57
- EV / EBIT
- 96.75
- 19.31
- EV / FCF
- 56.98
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 4.20%
- 10.8%
- Shares Change (QoQ)
- 0.34%
- 0.50%
- Float
- 114M
- 49M
- Shares Held by Insiders
- 9.32%
- 11.7%
- Shares Held by Institutions
- 104.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 18M
- –
- Short Interest Change
- -11.4%
- -0.80%
- Short % of Float
- 15.9%
- 9.01%
- Short % of Shares Outstanding
- 14.4%
- 6.30%
- Days to Cover
- 7.58
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $34.80
- –
- 52-Week Low
- $19.30
- –
- 20-Day Moving Average
- $30.33
- –
- 50-Day Moving Average
- $27.54
- –
- 200-Day Moving Average
- $25.38
- –
- Average True Range (14)
- $1.75
- –
- Price Change (1 Week)
- 10.6%
- -1.15%
- Price Change (1 Month)
- -2.89%
- -4.87%
- Price Change (3 Months)
- 10.3%
- -21.0%
- Price Change (6 Months)
- 32.6%
- -20.6%
- Price Change (YTD)
- -2.69%
- -23.6%
- Price Change (1 Year)
- 20.5%
- -22.4%
- Price Change (3 Years)
- 1196.3%
- -29.5%
- Price Change (5 Years)
- 33.4%
- -77.9%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.37
- 0.70
- Relative Strength Index (14)
- 48.3
- 43.4
- Volatility (1 Year)
- 56.5%
- 80.1%
- Beta (5 Years)
- 0.92
- 1.07
MarginsIndustry
- EBITDA Margin
- 6.91%
- -27.7%
- FCF Margin
- 11.7%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 14.9%
- -49.9%
- Return on Assets (ROA)
- 6.68%
- -40.6%
- Return on Invested Capital (ROIC)
- 32.9%
- -32.9%
- Return on Capital Employed (ROCE)
- 9.99%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.92
- 3.30
- Quick Ratio
- 2.50
- 2.39
- Debt / Equity
- 0.45
- 0.49
- Debt / EBITDA
- 3.11
- 3.15
- Debt / FCF
- 1.83
- 4.65
- Net Debt / EBITDA
- -4.27
- 1.97
- Interest Coverage
- 2.56
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 60.0%
- 6.82%
- Revenue Growth (3Y CAGR)
- 367.3%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 1.14
- 0.40
- Inventory Turnover
- 1.32
- 2.73
- Revenue Per Employee
- $1.44M
- $429.29K
- Profits Per Employee
- $84.49K
- -$689.41K
- Employee Count
- 354
- 74
- WACC
- 9.69%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $150.06M
- $17.76M
- Net Cash Per Share
- $1.19
- $0.80
- Equity (Book Value)
- $243.97M
- $53.89M
- Book Value Per Share
- $1.94
- $1.50
- Tangible Book Value
- $230.84M
- $27.13M
- Working Capital
- $331.33M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$255.00K
- -$1.00M
- FCF Per Share
- $0.48
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 0.84%
- -21.8%
- FCF Yield
- 1.68%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $13.73M
- $2.90M
- Income Tax
- $894.00K
- $73.00K
Scores and fair valueIndustry
- Graham Number
- $3.10
- $19.34
- Graham Upside
- -89.0%
- -46.6%
- Altman Z-Score
- 6.54
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ARQT | S&P 500 | Difference | ARQT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.3% | -3.0% | +11.4 pts | ||
| 3 months | +9.4% | -2.8% | +12.2 pts | ||
| Year to date | -2.7% | +11.5% | −14.2 pts | ||
| 1 year | +23.6% | +13.5% | +10.2 pts | ||
| 3 years | +1239.3% | +77.7% | +1161.6 pts | +137.5% | +21.1% |
| 5 years | +33.4% | +72.6% | −39.2 pts | +5.9% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
18M ARQT shares were sold short on Oct 30, 2026, down 11.4% from the previous report, or 15.93% of the shares available to trade. At recent volumes it would take 7.6 days to buy them back. Over the last 20 sessions, 56.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 18,157,145 | -11.4% | 2,396,041 | 7.6 |
| Oct 15, 2026 | 20,485,453 | -5.5% | 2,095,240 | 9.8 |
| Sep 30, 2026 | 21,688,918 | +17.5% | 4,493,016 | 4.8 |
| Sep 15, 2026 | 18,458,091 | +11.5% | 2,161,716 | 8.5 |
| Aug 31, 2026 | 16,557,048 | +12.5% | 1,759,643 | 9.4 |
| Aug 14, 2026 | 14,717,905 | +16.0% | 1,830,937 | 8.0 |
| Jul 31, 2026 | 12,686,384 | -6.5% | 1,180,842 | 10.7 |
| Jul 15, 2026 | 13,561,565 | -3.3% | 1,451,742 | 9.3 |
| Jun 30, 2026 | 14,019,289 | -11.4% | 2,213,503 | 6.3 |
| Jun 15, 2026 | 15,820,721 | -2.5% | 1,575,149 | 10.0 |
| May 29, 2026 | 16,226,183 | -7.5% | 1,922,091 | 8.4 |
| May 15, 2026 | 17,547,517 | +4.0% | 2,403,752 | 7.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?